 |
| juLY
24, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
BIG4BIO
CEO WEEKLY Q&A:
Joseph Tucker, Ph.D., CEO & Director,
Enveric Biosciences |
| In this
Q&A, Tucker explains what set Enveric
apart from the first wave of psychedelic
biotech companies: rather than rushing
traditional molecules into the clinic, the
team chose to do the harder medicinal
chemistry work — designing
non-hallucinogenic compounds that might
deliver the therapeutic benefits of
psychedelic-inspired pharmacology without
the practical barriers that limit
scalability. More |
|
|
- Beckman
Coulter Diagnostics: Launches Fully Automated
Urinalysis System to Meet Rising Testing
Volumes More
- Cedars
Sinai: AI Analyzes Surgical Technique to
Improve Prostate Cancer Care More
- eXoZymes:
Selected for DoE's Genesis Mission to
Advance AI-Powered Digital Twins for
Cell-Free Biomanufacturing More
- MannKind:
FDA Approval of Furoscix ReadyFlow, the
First and Only Autoinjector Delivering
IV-Equivalent Diuretic Therapy for the
Treatment of Edema in Adults With Heart
Failure or Chronic Kidney Disease More
- NeuraNova:
Receives FDA 510(k) Clearance for STEDI Device
More
- NovoMed
PARTNERS: Officially Launches to Build the
Next Generation of Transformative Medical
Technology Companies More
- OneLegacy:
Partners With OrganOx to Transform Liver
Transplantation, Offering Advanced Medical
Solutions to Transplant Centers in Southern
California More
- USC:
Study Reveals How Networks of Switches in DNA,
Which Control Gene Expression, Drive Cancer
Growth More
|
|
- Edwards
Lifesciences: Second Quarter Results More
- LSN:
Hot Investor Mandates (Updated 7/21) More
- MannKind:
$50 Million Private Placement More
- Two
Years to Build or Pay 200% — Which US Pharma
Stocks Win? More*
|
|
- Autism-Like Traits in Mice Improved After
Single Rapamycin Dose More
- Big4Bio CEO Weekly Q&A: Joseph
Tucker, Ph.D., CEO & Director, Enveric
Biosciences More
- CollectiveMinds: Executive Search
Built Exclusively for Life Sciences More
- Midlife Brain Aging Linked to Immune
Cell Remodeling, Blood-Brain Barrier Decline
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
-
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Biopharma Layoffs Must Double in H2 for 2026
to Match 2025 Cuts More
- Fierce Biotech Layoff Tracker 2026: Clinuvel
Cuts Fifth of Staff; Novartis Loses 322
Workers
More
- ICYMI: Slone Partners - How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare
More
- Make or Break: Commercial Hires Critical for
Success More
- Michael Ehlers Joins Formation Bio to Lead
R&D; Black Diamond Co-Founder Dies at 67 More*
- OPPORTUNITY: Computational Scientist, NY
More
- OPPORTUNITY: President, PA More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- Slone Partners: The Urgency of
Succession Planning for Hospitals and
Healthcare Delivery Systems More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
